Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
William Andrew Macan, Executive Vice President and General Counsel at Neuronetics , Inc. (NASDAQ:STIM), recently sold 18,965 shares of the company’s common stock. The shares were sold at a weighted average price of $4.11, netting a total of $77,946. Following this transaction, Macan holds 369,682 shares directly. The transaction comes as STIM shares have shown remarkable momentum, with a 289% surge over the past six months and currently trading near their 52-week high of $5.07. According to InvestingPro analysis, the stock appears to be trading above its Fair Value.
The sale, executed on February 14, 2025, was a non-discretionary transaction to satisfy tax withholding obligations upon the vesting of a restricted stock unit award. The shares were sold at prices ranging from $3.99 to $4.27. InvestingPro subscribers can access 13 additional expert tips and comprehensive insider trading analysis through the Pro Research Report, helping investors make more informed decisions about STIM’s current market position and momentum.
In other recent news, Neuronetics, a global leader in neuroscience, has unveiled a public offering of its common stock, with Canaccord Genuity LLC acting as the sole bookrunner for the transaction. The completion of this offering depends on market and other conditions. It’s important to note that the sale of shares is in accordance with a shelf registration statement filed with the U.S. Securities and Exchange Commission earlier.
On another note, Neuronetics released its preliminary unaudited revenue for the fourth quarter and the full year of 2024, reporting revenues of $22.1 million and $74.5 million respectively. Following the acquisition of Greenbrook TMS, a network of mental health treatment clinics, the company’s pro forma consolidated revenue was adjusted to $34.7 million for the fourth quarter and $129.8 million for the full year of 2024.
Looking ahead, Neuronetics expects a revenue range of $145.0 million to $155.0 million for fiscal year 2025, which would represent a 12% to 19% increase on a pro forma basis. The company also aims to achieve cash flow breakeven in the third quarter of the year. These recent developments highlight the company’s strategic moves and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.